A detailed history of Black Rock Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,466,935 shares of BBIO stock, worth $265 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,466,935
Previous 10,156,773 3.05%
Holding current value
$265 Million
Previous $410 Million 21.07%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$27.35 - $40.45 $8.48 Million - $12.5 Million
310,162 Added 3.05%
10,466,935 $324 Million
Q4 2023

Feb 13, 2024

BUY
$24.02 - $43.89 $21.8 Million - $39.8 Million
906,830 Added 9.8%
10,156,773 $410 Million
Q3 2023

Nov 13, 2023

SELL
$16.89 - $35.01 $5.6 Million - $11.6 Million
-331,786 Reduced 3.46%
9,249,943 $244 Million
Q2 2023

Aug 11, 2023

BUY
$13.29 - $18.01 $6.17 Million - $8.36 Million
463,948 Added 5.09%
9,581,729 $165 Million
Q1 2023

May 12, 2023

SELL
$7.17 - $18.55 $4.66 Million - $12.1 Million
-650,410 Reduced 6.66%
9,117,781 $151 Million
Q4 2022

Feb 13, 2023

BUY
$6.74 - $11.52 $3.39 Million - $5.79 Million
502,323 Added 5.42%
9,768,191 $74.4 Million
Q3 2022

Nov 14, 2022

SELL
$7.94 - $12.36 $736,141 - $1.15 Million
-92,713 Reduced 0.99%
9,265,868 $92.1 Million
Q2 2022

Aug 12, 2022

BUY
$5.21 - $12.14 $1.12 Million - $2.6 Million
214,374 Added 2.34%
9,358,581 $85 Million
Q1 2022

May 12, 2022

SELL
$7.34 - $17.16 $964,351 - $2.25 Million
-131,383 Reduced 1.42%
9,144,207 $92.8 Million
Q4 2021

Feb 10, 2022

SELL
$11.38 - $53.41 $9.85 Million - $46.2 Million
-865,721 Reduced 8.54%
9,275,590 $155 Million
Q3 2021

Nov 09, 2021

BUY
$46.87 - $64.24 $30 Million - $41.2 Million
640,990 Added 6.75%
10,141,311 $475 Million
Q2 2021

Aug 11, 2021

BUY
$46.47 - $63.93 $441 Million - $607 Million
9,500,321 New
9,500,321 $579 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.76B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.